Previous close | 454.90 |
Open | 454.90 |
Bid | 402.55 |
Ask | 409.30 |
Strike | 340.00 |
Expiry date | 2025-01-17 |
Day's range | 454.90 - 454.90 |
Contract range | N/A |
Volume | |
Open interest | 67 |
An FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.
CAVA, Abercrombie & Fitch, Eli Lilly, CrowdStrike and Deckers Outdoor have been highlighted in this Market Edge article.
These 5 stocks are red hot and hitting new all-time highs. Have you missed the trade?